DOI: 10.1055/s-00000069

Seminars in Liver Disease

Ausgabe 01 · Volume 36 · Februar 2016 DOI: 10.1055/s-006-30988 New Treatments in Liver Disease Guest Editors, Gregory J. Gores, MD, and Ariel E. Feldstein, MD

Editorial

001
Berk, Paul D.: A Farewell to Arms
003
Bruix, Jordi; Gores, Gregory J.: Inheriting a Jewel: A Thrilling Challenge

005
Williamson, Kate D.; Chapman, Roger W.: New Therapeutic Strategies for Primary Sclerosing Cholangitis
015
Corpechot, Christophe: Primary Biliary Cirrhosis Beyond Ursodeoxycholic Acid
027
Wree, Alexander; Mehal, Wajahat Z.; Feldstein, Ariel E.: Targeting Cell Death and Sterile Inflammation Loop for the Treatment of Nonalcoholic Steatohepatitis
037
Anand, Gobind; Zarrinpar, Amir; Loomba, Rohit: Targeting Dysbiosis for the Treatment of Liver Disease
048
Rahimi, Robert S.; Rockey, Don C.: Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia
056
Singal, Ashwani K.; Shah, Vijay H.: Therapeutic Strategies for the Treatment of Alcoholic Hepatitis
069
Fuchs, Claudia D.; Traussnigg, Stefan A.; Trauner, Michael: Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease
087
Yoon, Young Joon; Friedman, Scott L.; Lee, Youngmin A.: Antifibrotic Therapies: Where Are We Now?

Diagnostic Problems in Hepatology

099
Schneier, Amanda; Stueck, Ashley E.; Petersen, Bruce; Thung, Swan N.; Perumalswami, Ponni: An Unusual Cause of Acute Liver Failure: Three Cases of Hemophagocytic Lymphohistiocytosis Presenting at a Transplant Center